secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001558370-24-003889
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 5.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO raises $8.6M in private placement of Series G convertible preferred stock
--------------------------------------------------------------------------------

- Gross proceeds of $8.6 million from sale of 10,901 Series G Preferred shares at $788.90 each.
- Each Series G share initially convertible into 100 common shares, subject to 9.99% beneficial ownership limitation.
- Closing expected on March 26, 2024; offering exempt under Section 4(a)(2) and Regulation D.
- Company filed Certificate of Designations with Delaware establishing Series G Preferred Stock terms.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000155837024003889/0001558370-24-003889-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000155837024003889/kala-20240325x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-003889

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer